Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00277082 · ClinicalTrials.gov registry record
Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung
A clinical trial, sponsored by University of New Mexico.
- Completed
- Registry status
- 24
- Enrollment target
NCT00277082 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 24 participants.
The verdict
NCT00277082 has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
To determine the concentration of 9-nitrocamptothecin (9NC) in the alveolar fluid over time. 1.2. To determine the arterial concentration of 9NC administered by inhalation in comparison to venous and urine concentrations. 1.3. To determine the tumor concentration of 9NC administered by inhalation
Interventions
- DRUG 9-NC in aerosol reservoir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2003-08 |
| Est. Completion | 2005-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00277082
The ClinicalTrials.gov registry entry for NCT00277082 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 9-NC in aerosol reservoir is the first listed.
NCT00277082 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00277082 about?
NCT00277082 is a clinical study titled "Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung". To determine the concentration of 9-nitrocamptothecin (9NC) in the alveolar fluid over time. 1.2. To determine the arterial concentration of 9NC administered by inhalation in comparison to venous and urine concentrations. 1.3. To determine the tumor concentration of 9NC administered by inhalation
What is the current status of trial NCT00277082?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2003-08. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00277082?
The interventions under investigation include: 9-NC in aerosol reservoir (DRUG).
Who is sponsoring clinical trial NCT00277082?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.